Canadian Letter: Medexus Pharma will head even higher, says Raymond James https://www.cantechletter.com/2023/08/medexus-pharma-will-head-even-higher-says-raymond-james/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #mdp
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #mdp
Canadian Letter: ProMIS Neuroscience heading to $26, says Leede Jones Gable https://www.cantechletter.com/2023/07/promis-neuroscience-heading-to-26-says-leede-jones-gable/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #pmn
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #pmn
Canadian Letter: Medexus Pharma is a “compelling opportunity,” says Echelon https://www.cantechletter.com/2023/07/medexus-pharma-is-a-compelling-opportunity-says-echelon/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #mdp
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #mdp
Canadian Letter: Theratechnologies is a Buy, says Research Capital https://www.cantechletter.com/2023/07/theratechnologies-is-a-buy-says-research-capital-3/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #thtx
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #thtx
Canadian Letter: Theratechnologies has target slashed by Leede Jones Gable https://www.cantechletter.com/2023/07/theratechnologies-has-target-slashed-by-leede-jones-gable/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #th
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #th
Canadian Letter: Panbela Therapeutics has a huge upside, says Roth https://www.cantechletter.com/2023/07/panbela-therapeutics-has-a-huge-upside-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #pbla
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #pbla
Canadian Letter: Buy Aslan Pharma on the pullback, says Roth https://www.cantechletter.com/2023/07/buy-aslan-pharma-on-the-pullback-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #asln
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #asln
Canadian Letter: Cipher Pharma is a Buy, says Leede Jones Gable https://www.cantechletter.com/2023/07/cipher-pharma-is-a-buy-says-leede-jones-gable/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #cph
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #cph
Canadian Letter: DRI Healthcare keeps Outperform rating with Raymond James https://www.cantechletter.com/2023/07/dri-healthcare-keeps-outperform-rating-with-raymond-james/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #dht.u
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #dht
Canadian Letter: Medexus Pharma is a Buy, says Roth https://www.cantechletter.com/2023/07/medexus-pharma-is-a-buy-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #mdp
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #mdp
Canadian Letter: Antibe Therapeutics has a 317 per cent upside, says Echelon https://www.cantechletter.com/2023/06/antibe-therapeutics-has-a-317-per-cent-upside-says-echelon/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #ate
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #ate
Canadian Letter: Plenty of upside to biotech stock Genenta Science, says Roth https://www.cantechletter.com/2023/06/plenty-of-upside-to-biotech-stock-genenta-science-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #gnta
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #gnta
Canadian Letter: Point Biopharma is heading to $13, says Raymond James https://www.cantechletter.com/2023/06/point-biopharma-is-heading-to-13-says-raymond-james/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #pnt
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #pnt
Canadian Letter: Fusion Pharmaceuticals has tons of upside, says Raymond James https://www.cantechletter.com/2023/06/fusion-pharmaceuticals-has-tons-of-upside-says-raymond-james/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #fusn
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #fusn
Canadian Letter: Arch Biopartners is a pass, says Raymond James https://www.cantechletter.com/2023/06/arch-biopartners-is-a-pass-says-raymond-james-2/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #arch
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #arch
Canadian Letter: Eupraxia Pharmaceuticals is a Strong Buy, says Raymond James https://www.cantechletter.com/2023/06/eupraxia-pharmaceuticals-is-a-strong-buy-says-raymond-james/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #eprx
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #eprx
Canadian Letter: Mindset Pharma has tons of upside, says Echelon https://www.cantechletter.com/2023/06/mindset-pharma-has-tons-of-upside-says-echelon/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #mset
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #mset
Canadian Letter: Fusion Pharmaceuticals is a triple, says Raymond James https://www.cantechletter.com/2023/06/fusion-pharmaceuticals-is-a-triple-says-raymond-james/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #fusn
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #fusn
Canadian Letter: Medexus Pharmaceuticals has an Outperform rating with Raymond James https://www.cantechletter.com/2023/06/medexus-pharmaceuticals-has-an-outperform-rating-with-raymond-james/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #mdp
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #mdp
Canadian Letter: Mind Medicine has a huge upside, says Roth https://www.cantechletter.com/2023/06/mind-medicine-has-a-huge-upside-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #mnmd
#Canada #Tech #technology #PharmaandBiotech #Allposts #Analysts #mnmd